Loading clinical trials...
Loading clinical trials...
A Randomized, Placebo-controlled, 2-way Crossover, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of JNJ-42847922 in Subjects With Insomnia Disorder Without Psychiatric Comorbidity
Conditions
Interventions
JNJ-42847922
Placebo
Locations
5
United States
Hollywood, Florida, United States
Berlin, Germany
Hamburg, Germany
Schwerin, Germany
Leiden, Netherlands
Start Date
July 27, 2015
Primary Completion Date
December 2, 2015
Completion Date
December 2, 2015
Last Updated
April 27, 2025
NCT05780177
NCT06373718
NCT05393830
NCT07384429
NCT06032377
NCT06181643
Lead Sponsor
Janssen Research & Development, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions